# Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System

> **NCT02276547** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Shockwave Medical, Inc.** · enrollment: 27 (actual)

## Conditions studied

- Mitral Valve Regurgitation

## Interventions

- **DEVICE:** Mitral valve replacement

## Key facts

- **NCT ID:** NCT02276547
- **Lead sponsor:** Shockwave Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-12
- **Primary completion:** 2020-01-06
- **Final completion:** 2025-08
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02276547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02276547, "Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02276547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*